Garber A, Henry RR, Ratner R, Hale P, Chang CT, Bode B
Foundayo (with the core ingredient Orforglipron) is a once-daily small molecule (non-peptide) oral GLP-1 receptor agonist, The "small molecule" is actually important to keep in mind, because unlike Semaglutide, which is a peptide drug requiring strict handling conditions, Orforglipron is a small molecule, meaning it follows standard small-molecule chemistry and doesn't require the same formulation complexity as peptide-based GLP- Foundayo was FDA approved on April 1st, really no joke
How GHK-Cu and Retinol Work at the Cellular Level These two ingredients don't just produce different results
Understanding these options allows researchers to select the approach best suited to their specific goals and circumstances
Mood + focus: Am I calmer around food decisions
More collections Nutrient-dense meals that fit your life schedule goals budget dietary needs